OBJECTIVE To describe patients younger than 18 years who were infected with ZIKV and were enrolled in the Sentinel Enhanced Dengue and Acute Febrile Illness Surveillance System (SEDSS).
Z ika virus (ZIKV) is a single-stranded RNA flavivirus (genus Flavivirus, family Flaviviridae) that is closely related to the dengue virus (DENV) and other flaviviruses (eg, West Nile virus, Japanese encephalitis, and yellow fever). 1 Infections of ZIKV can be transmitted to humans by the bite of infected Aedes mosquitoes, 2,3 from mother to child, [4] [5] [6] and through sexual transmission, 7, 8 laboratory exposure, 9 and transplantation or transfusion of blood or blood products. 10 Zika virus has been detected in breast milk, 6, 11, 12 but transmission of ZIKV through breastfeeding has not been confirmed. First discovered in 1947, 13 ZIKV has been reported in more than 70 countries worldwide. 14 From November 2015, through December 2016, more than 38 000 cases of ZIKV infection were reported in Puerto Rico. 15 Infection with ZIKV is either asymptomatic or mildly symptomatic, and infection resulting in neurologic illness (eg, Guillain-Barré syndrome), hospitalization, or death is unusual. 15 Infection during pregnancy may lead to severe adverse fetal and infant outcomes, including congenital Zika syndrome. 16 Limited information is available regarding the clinical manifestations of ZIKV infection in the pediatric population or regarding concentrations of ZIKV in bodily fluids in any population. Active surveillance for acute febrile illnesses, including ZIKV infection, is ongoing through the Sentinel Enhanced Dengue and Acute Febrile Illness Surveillance System (SEDSS) in Ponce, Puerto Rico. Our objective was to describe the clinical manifestations and viral loads of pediatric patients who had symptomatic ZIKV infection and who were enrolled in SEDSS on or before December 31, 2016.
Methods
Since 2012, active enrollment in SEDSS has been conducted in Ponce, Puerto Rico, at the San Lucas Episcopal Hospital (SLEH) and, more recently (since April 2016), at Centro de Emergencia y Medicina Integrada, an affiliated clinic, in collaboration with the Ponce Health Sciences University. As a 425-bed, tertiary care teaching hospital and 1 of 4 hospitals serving almost 500 000 residents of Ponce and 11 neighboring municipalities, SLEH has approximately 50 000 emergency department visits and 11 000 hospital admissions each year. Patients presenting to the emergency department, to Centro de Emergencia y Medicina Integrada, or directly admitted to an inpatient ward at SLEH, were eligible for enrollment if they were febrile (oral temperature, ≥38.0°C; axillary temperature, ≥38.5°C) or had a fever for 7 or fewer days. In June 2016, the inclusion criteria were expanded to capture a higher number of suspected cases of ZIKV. Adult, and emancipated minors aged 14 to 20 years presenting with the acute onset of a generalized maculopapular rash, arthritis or arthralgia, or nonpurulent conjunctivitis became eligible for enrollment into SEDSS. The institutional review boards at the Centers for Disease Control and Prevention (CDC) and the Ponce Health Sciences University approved the study protocol. Written informed consent was obtained from eligible individuals older than 20 years, emancipated minors aged 14 to 20 years, and the parent or guardian of children aged 7 years or younger. Written informed assent was obtained from nonemancipated minors aged 14 to 20 years, with written informed consent obtained from the parent or guardian. Verbal informed assent was obtained from children aged 7 to 13 years, with written informed consent obtained from the parent or guardian.
Symptoms of the current acute febrile illness, various exposures, and a history of chronic diseases were obtained from each participant at the time of enrollment. An independent physician examined the participants, and their vital signs were recorded. Signs and symptoms of the current illness were noted, and the clinical diagnosis was recorded. Participants discharged to home from the emergency department were asked to return 7 to 10 days after the onset of illness. Participants who were hospitalized had the medical record of their hospitalization summarized.
Following standard procedures, participants provided 2 samples of blood at enrollment: a 7-mL sample collected in a red, tiger-top serum separator tube and a 5-mL sample collected in a lavender-top tube. For participants younger than 4 years, the amount of blood drawn was based on weight, with the maximum amount of blood drawn not more than 2.5 mL/kg. Blood samples were processed on site where patients were evaluated (SLEH or Centro de Emergencia y Medicina Integrada). Nasopharyngeal and oropharyngeal secretions were collected separately with sterile, polyester specimen-collection swabs. These specimens were placed in a vial containing viral transport medium. A 5-mL sample of urine was also collected. Inoculated vials and blood, serum, and urine specimens were maintained at 4°C until they were transported to the Dengue Branch Laboratory of the CDC in San Juan, Puerto Rico.
Molecular diagnostic testing was performed on specimens collected 6 or fewer days after the onset of illness for the detection of ZIKV, DENV, chikungunya virus (CHIKV), adenovirus, metapneumovirus, influenza A virus, influenza B virus, respiratory syncytial virus, and parainfluenza viruses 1 and 3. Viral RNA was extracted from 200 μL of serum, urine, whole blood-
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Question What are the clinical manifestations and viral loads of symptomatic infants, children, and adolescents infected with Zika virus?
Findings In this cohort of 351 infants, children, and adolescents with Zika virus infection in Puerto Rico, most had fever, an often pruritic maculopapular rash, facial or neck erythema, and conjunctival hyperemia; presented for evaluation at fewer than 3 days after the onset of symptoms; and were discharged without hospitalization. Median viral loads obtained from the serum specimens differed significantly according to the number of days after the onset of symptoms.
Meaning Symptomatic infants, children, and adolescents infected with Zika virus generally have a mild, often nonspecific illness not requiring hospitalization; and, although not significantly different according to age, sex, or disposition, Zika virus viral loads decreased with an increasing number of days since the onset of illness.
EDTA, or nasopharyngeal or oropharyngeal specimens using an automated platform (MagNA Pure 96; Roche). The DENV, CHIKV, and ZIKV were detected with a reverse transcriptasepolymerase chain reaction (RT-PCR) assay (Trioplex Real-Time RT-PCR; CDC) approved by the US Food and Drug Administration under emergency use authorization, and respiratory viruses were detected using virus panel assays (Influenza and Non-influenza Respiratory Virus Panel assays; CDC). Viral loads of ZIKV were quantified using an RNA standard curve generated from the RT-PCR assay's ZIKV target amplicons and were expressed as copies per milliliter. At the follow-up visit or at discharge from the hospital, blood and urine specimens were collected from the patient. Samples of serum collected 4 or more days after the onset of illness were tested for the presence of anti-DENV IgM, anti-CHIKV IgM, and anti-ZIKV IgM using enzyme-linked immunosorbent assays (ELISAs). The following assays were used to detect anti-DENV and anti-CHIKV IgM: DENV Detect IgM Capture MAC-ELISA (Inbios International Inc) and CHIKV IgM MAC-ELISA (CDC), respectively. Anti-ZIKV IgM was detected with the ZIKV IgM Capture MAC-ELISA (CDC) approved by the US Food and Drug Administration under emergency use authorization.
The study population for this analysis comprised individuals younger than 18 years who were enrolled in SEDSS on or before December 31, 2016, with confirmed ZIKV infection. A positive result for ZIKV on the CDC Trioplex Real-Time RT-PCR assay confirmed ZIKV infections. For patients enrolled more than once in SEDSS, only data from the initial enrollment in SEDSS were analyzed.
Descriptive analysis included calculation of frequencies of the demographic characteristics, the signs and symptoms, and the disposition for all participants by age group. Median and range results were calculated for continuous variables. The Cochran-Armitage test (for trend in proportions) and the Jonckheere-Terpstra test (for ordered alternatives in the medians) were used to assess trends. The χ 2 test was used to measure association. For paired samples with viral load estimation, the Mann-Whitney-Wilcoxon rank sum test was used to compare medians of viral load by type of specimen.
To identify clusters of signs and symptoms for the participants, the unsupervised grouping method of hierarchical cluster analysis was used. Clusters of signs and symptoms were determined for the patient population overall and by each age group using signs and symptoms reported by more than 50% of the participants. To determine the optimal number of clusters, the NbClust function incorporating Duda and Beale indices with a significance of .05 from the NbClust R-package was used. 17 Similarities among signs and symptoms were measured using the sum of the absolute difference (Manhattan distance). 18, 19 Manhattan distance as well as other distances used in hierarchical clustering analysis do not have units.
Manhattan distance is a special case of the Minkowski distance at m = 1. It is very sensitive to outliers, and it is used in clustering algorithms specially for the binary nature of vectors (absence or presence of symptoms). Signs and symptoms were grouped into the specified number of clusters by minimizing the total within-cluster variance (the Ward agglomeration method). 20 Symbols at the termination of each dendrogram branch identify signs and symptoms that belong to the same cluster. Statistical analysis was performed using R, version 3.1 (R Foundation for Statistical Computing) and R-Studio Integrated Development Environment for R (R-Studio, Inc).
Results
As of December 31, 2016, 7191 individuals younger than 18 years met the eligibility criteria and were enrolled in SEDSS. Of these 7191 pediatric patients, 351 had PCR-confirmed ZIKV infection. Two patients with confirmed infections of ZIKV were enrolled twice in SEDSS; only data from the first enrollment were analyzed. Figure 1 shows the distribution of all 351 pediatric patients enrolled into SEDSS according to the month of enrollment. Characteristics of the 351 infants, children, and adolescents in the study population are shown in Research Original Investigation Symptomatic Zika Virus Infection in Infants, Children, and Adolescents Living in Puerto Rico in 2016 P = .003). The median age of the children who were hospitalized was 3.5 years (range, 1 month to 11 years). The 10 children hospitalized were admitted because of vomiting, diarrhea, dehydration, and/or anorexia (n = 6); respiratory distress due to pneumonia or bronchiolitis (n = 3); and clinical sepsis (n = 1 Four adolescent girls were pregnant at the time of enrollment into SEDSS, and all of the girls received pregnancyrelated care at SLEH. A 17-year-old girl who was 4 weeks pregnant at the time of enrollment underwent ultrasonography at 12 weeks' gestation; the results revealed fetal demise (intrauterine pregnancy of 9 weeks, 3 days). The other 3 adolescent girls (aged 14, 17, and 17 years) delivered full-term (38-39 weeks' gestation), phenotypically normal newborns. All newborns were reported at birth to be without structural abnormalities; 2 newborns underwent postnatal cranial imaging and the results were without demonstrated pathologic features, and 1 newborn had been evaluated by in utero ultrasonography with interpreted results within normal limits. Thirteen children (3.7%) had evidence of a concomitant infection. The detected coinfections were parainfluenza 3 (n = 4), adenovirus (n = 3), influenza B virus (n = 3), influenza A virus (n = 2), and human metapneumovirus (n = 1).
Clusters of signs and symptoms more likely to have occurred together were formed using hierarchical clustering, with similarities measured by distance as described above. The resulting cluster dendrograms are shown in Figure 2 and Figure 3 , with distance shown on the x-axis. In the cohort of 351 infants, children, and adolescents (Figure 2 ), there were 3 clusters: 156 patients (44.4%) who had pruritus, facial or neck erythema, and fever with rash; 137 (39.0%) who had fatigue with general malaise; and 109 (31.0%) who had headache and chills with conjunctival hyperemia. Among 25 infants ( Figure 3A ), there were 2 clusters: 8 infants (32.0%) who had irritability with cough and 11 infants (44.0%) who had fatigue, fever, and facial or neck erythema with rash. Of 69 children aged 1 to 4 years ( Figure 3B ), there were 3 clusters: 29 children (42.0%) who had pruritus, fever, and rash with facial or neck erythema; 23 children (33.3%) who had rhinorrhea with chills; and 20 children (29.0%) who had anorexia and fatigue with conjunctival hyperemia. Among the 95 children aged 5 to 9 years ( Figure 3C ), there were 3 clusters: 42 children (44.2%) who had pruritus, facial or neck erythema, and fever with rash; 37 children (39.0%) who had chills with conjunctival hyperemia; and 38 children (40.0%) who had headache with fatigue. Of 162 children aged 10 to 17 years ( Figure 3D ), there were 5 clusters: 86 children (53.1%) who had pharyngitis; 51 (31.5%) who had general malaise, arthralgia, and myalgia with bone pain; 81 (50.0%) who had facial or neck erythema and rash with pruritus; 74 (45.7%) who had conjunctival hyperemia with eye pain; and 81 (50.0%) who had fatigue, chills, and fever with headache.
Of the 351 children in the study population, 349 had 1 or more specimens available for viral quantification ( Table 2) . Among the 480 specimens (317 serum and 163 urine specimens), the median viral load was 19 603 copies/mL (interquartile range, 5393-95 598 copies/mL). However, the median number of days after onset by specimen collection was lower (1 day [interquartile range, 1-2 days]) for children who submitted a serum specimen than for children who submitted a urine specimen (2 [1-3] days) (P < .001). When we analyzed only serum and urine specimens collected on the same day for 131 patients, the median viral load was higher in serum than in urine (median [interquartile range], 23 098 copies/mL [8784-88 242 copies/mL] for serum vs 9966 [2815-52 774] copies/mL for urine; P = .02). When we analyzed a single serum sample from each of the 317 patients, there were no statistically significant differences in the median viral loads according to age, sex, or disposition after evaluation. However, the median viral loads in serum varied significantly according to the number of days after the onset of illness (0 days, 106 778 copies/mL [interquartile range, 9772-1 571 718 copies/mL]; 1 day, 46 299 copies/mL [10 663-255 030]; 2 days, 20 678 copies/mL [8763-42 458]; and 3 or more days, 15 901 copies/mL [5135-49 248]; P = .001).
Discussion
In this cohort of 351 symptomatic individuals younger than 18 years with confirmed ZIKV infection, most presented for care fewer than 3 days after the onset of symptoms. Most were discharged to home from the emergency department; less than 3% were hospitalized or transferred to another hospital. Aside from fever, other signs and symptoms experienced by most patients were fatigue, headache, chills, pruritus, maculopapular rash, facial or neck erythema, and conjunctival hyperemia. The proportion of patients who had headache increased with the age of the child, whereas the proportion of patients with irritability decreased with the age of the child. Clustering of signs and symptoms varied by age; among infants, irritability with cough was prominent; among older children and adolescents, clusters of signs and symptoms with headache. Adolescents often reported only pharyngitis or clusters of signs or symptoms involving myal- gia, arthralgia, bone pain, or eye pain. The median viral load was higher in serum than in urine specimens. In serum samples, there were no statistically significant differences in the median viral loads according to age, sex, or disposition after evaluation. However, the median viral load varied significantly according to days after the onset of illness, with a decrease in the viral load as the number of days after onset increased.
Our results are consistent with previous reports suggesting that the clinical manifestations of symptomatic ZIKV infection are generally mild and that severe illness is unusual. Between 1964 (when the initial case of natural ZIKV infection in humans was reported) 9 26 and Brazil in 2015. 27 Of 49 confirmed cases of ZIKV infection in a Micronesian population with a median age of 36 years, most of the 31 individuals who provided information reported symptoms of macular or papular rash (90%), fever (65%), arthritis or arthralgia (65%), and nonpurulent conjunctivitis (55%). 26 Of 119 laboratory-confirmed ZIKV infections among a primarily adult population in Brazil, individuals presented with a macular or papular rash (97%), pruritus (79%), prostration (73%), headache (66%), arthralgia (63%), myalgia (61%), nonpurulent conjunctivitis (56%), and low back pain (51%). 27 In a case series of 14 children aged 16 years or younger from Singapore, 28 most children reported fever and rash, with myalgia, arthralgia, headache, conjunctivitis, and upper respiratory tract infections reported less frequently. Among 31 children aged 1 to 17 years with symptomatic ZIKV infection in Florida, all of the children reported a rash and 81% of them reported fever; only 29% had conjunctivitis, and 22% had arthralgia. 29 Finally, of 158 children younger than 18 years with confirmed or probable ZIKV disease reported to the CDC from US states, 30 fever and a rash were reported by most children, with conjunctivitis and arthralgia reported only in a minority of children. Because few data have been published to date regarding the viral loads of patients infected with ZIKV, the viral load results for this pediatric cohort contribute significantly, to our knowledge, not only because of the overall characteristics of the viral load of patients infected with ZIKV but also because of factors associated with higher viral loads, including the type of specimen (serum) and number of days (fewer) after the onset of symptoms. In a report from the outbreak of ZIKV in Yap State, Micronesia, in 2007, viral load results were reported for 17 patients who tested positive for ZIKV. 31 Among those patients, the estimated viral load values ranged from 930 to 625 280 copies/mL. Our study of more than 300 infants, children, and adolescents with symptomatic ZIKV infection represents the largest study to date of ZIKV infection in the pediatric population. All cases had PCR-confirmed ZIKV infection identified through an ongoing acute febrile illness surveillance system (SEDSS) in Puerto Rico. Only 4% of pediatric patients infected with ZIKV in this study had a concomitant infection with a respiratory virus.
Limitations
A potential limitation of this study is that postnatal infection, as opposed to congenitally acquired infection, is presumed. Mothers of children were not necessarily tested for ZIKV infection during the index pregnancy, and data regarding maternal ZIKV infection is not collected as part of SEDSS. But, the ZIKV epidemic in Puerto Rico only began in late 2015, and thus only infants would be affected by this possible limitation. Only 25 (7.1%) of the patients in this cohort were infants; all but 1 infant (aged 1 month) were 5 months or older at the time of enrollment into SEDSS. In our study population, the proportion of children with different signs and symptoms did not vary by age with the exception of headache, which increased as the age of the patient increased, and irritability, which decreased as the age of the patient increased. Although infants were excluded from the more detailed evaluations because they could not articulate localization of pain or discomfort, it is still possible that young children could not clearly communicate the localization of pain or discomfort. Thus, the statistically significant trend observed for headache according to age may be an artifact. Similarly, irritability was observed to decrease as the age of the child increased; older children may be able to more clearly communicate the location of their symptoms, whereas younger children who appear uncomfortable may be characterized as irritable. Since SEDSS is a surveillance system of febrile illnesses, the eligibility criteria resulted in the enrollment of febrile cases of ZIKV primarily, and the clinical presentation of children included in this analysis may not be representative of all symptomatic Zika cases in pediatric patients.
Conclusions
Most children with symptomatic infection of ZIKV had relatively mild illness not requiring hospitalization. Although several signs and symptoms occurred, 4 signs experienced by most children included fever, facial or neck erythema, conjunctival hyperemia, and a maculopapular rash that was often pruritic. The children presented for care soon after the onset of illness (<3 days), and almost all patients were discharged to home from the emergency department. Zika virus viral loads were higher in serum specimens than in urine. Age, sex, and disposition after evaluation did not affect viral loads, but ZIKV viral loads decreased significantly with increasing number of days after the onset of symptoms.
